abstract |
The present invention features methods and compositions for treatment of immunodeficiency virus infection. The compositions include isolated nucleic acid sequences comprising a CRISPR-associated endonuclease and a guide RNA, wherein the guide RNA is complementary to a target sequence in a human immunodeficiency virus. |